SlideShare a Scribd company logo
PsiNET Seminar Research Rare Disease and Social Media: an opportunity for the long tai l Luis Fernandez Luque, PhD Student Norut Tromsø (Norway) Manuel Armayones Ruiz, PhD Grupo de Investigación Psinet- Universitat Oberta de Catalunya (Spain) Co-founder  Asociación Española de Síndrome de Lowe [email_address] http://in3.uoc.edu/opencms/opencms/webs/grups_de_recerca/psinet/CA/
A disease or disorder is defined as rare in Europe when it affects less than 1 in 2000 citizens (Orphan Drug Regulation 141/2000). Rare diseases may affect 30 million European Union citizens . Rare diseases are characterised by a broad diversity of disorders and symptoms that vary not only from disease to disease but also from patient to patient suffering from the same disease. Relatively common symptoms can hide underlying rare diseases, leading to misdiagnosis .
Characteristics of rare diseases Rare diseases are often chronic, progressive, degenerative, and often life-threatening Rare diseases are disabling: the quality of life of patients is often compromised by the lack or loss of autonomy High level of pain and suffering for the patient and his/ her family No existing effective cure There are between 6000 and 8000 rare diseases 50% of rare diseases affect children 80% of rare diseases have identified genetic origins. Other rare diseases are the result of infections (bacterial or viral), allergies and environmental causes, or are degenerative and proliferative.
Rare disease patients face common problems: Lack of access to correct diagnosis Delay in diagnosis Lack of quality information on the disease Lack of scientific knowledge of the disease Heavy social consequences for patients Lack of appropriate quality healthcare Inequities and difficulties in access to treatment and care Source: Eurordis
 
Behind the data are real people with real problems http://www.youtube.com/watch?v=M7qirJXWhzc&feature=player_embedded
 
How can things change? By implementing a comprehensive approach to rare diseases By developing appropriate public health policies By increasing international cooperation in scientific research By gaining and sharing scientific knowledge about all rare diseases, not only the most “frequent” ones By developing new diagnostic and therapeutic procedures By raising public awareness By facilitating the network of patient groups to share their experience and best practices By supporting the most isolated patients and their parents to create new patient communities or patient groups By providing comprehensive quality information to the rare disease community Source: Eurordis

More Related Content

What's hot

Participatory rural appraisal of livestock diseases amongst a Fulani communit...
Participatory rural appraisal of livestock diseases amongst a Fulani communit...Participatory rural appraisal of livestock diseases amongst a Fulani communit...
Participatory rural appraisal of livestock diseases amongst a Fulani communit...
ILRI
 
Principles of control of communicable diseases dr.wah
Principles  of  control  of  communicable  diseases dr.wahPrinciples  of  control  of  communicable  diseases dr.wah
Principles of control of communicable diseases dr.wah
Mmedsc Hahm
 
Epidemiology and community health
Epidemiology and community healthEpidemiology and community health
Epidemiology and community healthSaleh Ahmed
 
One health in india
One health in indiaOne health in india
One health in india
Bhoj Raj Singh
 
Authorization and why families say yes
Authorization and why families say yesAuthorization and why families say yes
Authorization and why families say yesTeresaShafer
 
General epidemiology, Basic Epidemiology
General epidemiology, Basic EpidemiologyGeneral epidemiology, Basic Epidemiology
General epidemiology, Basic Epidemiology
Dr.Jatin Chhaya
 
Autism Caused by Vaccination
Autism Caused by VaccinationAutism Caused by Vaccination
Autism Caused by Vaccinationveronicafrias
 
Health Protection Inequalities - Time for an All Ireland Approach
Health Protection Inequalities - Time for an All Ireland ApproachHealth Protection Inequalities - Time for an All Ireland Approach
Health Protection Inequalities - Time for an All Ireland Approach
Institute of Public Health in Ireland
 
PREVENTION AND CONTROL OF INFECTIOUS DISEASE
PREVENTION AND CONTROL OF INFECTIOUS DISEASEPREVENTION AND CONTROL OF INFECTIOUS DISEASE
PREVENTION AND CONTROL OF INFECTIOUS DISEASEDr. Moses Bwana
 
Prevention of Healthcare Associated Infections
Prevention of Healthcare Associated InfectionsPrevention of Healthcare Associated Infections
Prevention of Healthcare Associated Infections
Nora Mahfouf
 
Developing Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case StudyDeveloping Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case Study
steelss
 
Friis chapter 1 slides
Friis chapter 1 slidesFriis chapter 1 slides
Friis chapter 1 slidestodd.damrow
 
Lyme Disease in Fairfax County
Lyme Disease in Fairfax CountyLyme Disease in Fairfax County
Lyme Disease in Fairfax County
Fairfax County
 
Health Protection Inequalities - A European Perspective
Health Protection Inequalities - A European Perspective Health Protection Inequalities - A European Perspective
Health Protection Inequalities - A European Perspective
Institute of Public Health in Ireland
 
Case Study of Inequalities
Case Study of Inequalities Case Study of Inequalities
Case Study of Inequalities
Institute of Public Health in Ireland
 
General epidemiology
General epidemiologyGeneral epidemiology
General epidemiology
Amany El-seoud
 
Epidemiology lecture of Community Medicine
Epidemiology lecture of Community Medicine Epidemiology lecture of Community Medicine
Epidemiology lecture of Community Medicine
Dr.Farhana Yasmin
 
Epidemiology-chn
Epidemiology-chnEpidemiology-chn
Epidemiology-chn
Anand Gowda
 
Problems of healthcare
Problems of healthcareProblems of healthcare
Problems of healthcareprof beso
 

What's hot (20)

Participatory rural appraisal of livestock diseases amongst a Fulani communit...
Participatory rural appraisal of livestock diseases amongst a Fulani communit...Participatory rural appraisal of livestock diseases amongst a Fulani communit...
Participatory rural appraisal of livestock diseases amongst a Fulani communit...
 
Principles of control of communicable diseases dr.wah
Principles  of  control  of  communicable  diseases dr.wahPrinciples  of  control  of  communicable  diseases dr.wah
Principles of control of communicable diseases dr.wah
 
Epidemiology and community health
Epidemiology and community healthEpidemiology and community health
Epidemiology and community health
 
One health in india
One health in indiaOne health in india
One health in india
 
Authorization and why families say yes
Authorization and why families say yesAuthorization and why families say yes
Authorization and why families say yes
 
General epidemiology, Basic Epidemiology
General epidemiology, Basic EpidemiologyGeneral epidemiology, Basic Epidemiology
General epidemiology, Basic Epidemiology
 
Autism Caused by Vaccination
Autism Caused by VaccinationAutism Caused by Vaccination
Autism Caused by Vaccination
 
Health Protection Inequalities - Time for an All Ireland Approach
Health Protection Inequalities - Time for an All Ireland ApproachHealth Protection Inequalities - Time for an All Ireland Approach
Health Protection Inequalities - Time for an All Ireland Approach
 
PREVENTION AND CONTROL OF INFECTIOUS DISEASE
PREVENTION AND CONTROL OF INFECTIOUS DISEASEPREVENTION AND CONTROL OF INFECTIOUS DISEASE
PREVENTION AND CONTROL OF INFECTIOUS DISEASE
 
Prevention of Healthcare Associated Infections
Prevention of Healthcare Associated InfectionsPrevention of Healthcare Associated Infections
Prevention of Healthcare Associated Infections
 
Developing Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case StudyDeveloping Urban Health Indicators for Low Income Countries: A Case Study
Developing Urban Health Indicators for Low Income Countries: A Case Study
 
Friis chapter 1 slides
Friis chapter 1 slidesFriis chapter 1 slides
Friis chapter 1 slides
 
Lyme Disease in Fairfax County
Lyme Disease in Fairfax CountyLyme Disease in Fairfax County
Lyme Disease in Fairfax County
 
Health Protection Inequalities - A European Perspective
Health Protection Inequalities - A European Perspective Health Protection Inequalities - A European Perspective
Health Protection Inequalities - A European Perspective
 
Document
DocumentDocument
Document
 
Case Study of Inequalities
Case Study of Inequalities Case Study of Inequalities
Case Study of Inequalities
 
General epidemiology
General epidemiologyGeneral epidemiology
General epidemiology
 
Epidemiology lecture of Community Medicine
Epidemiology lecture of Community Medicine Epidemiology lecture of Community Medicine
Epidemiology lecture of Community Medicine
 
Epidemiology-chn
Epidemiology-chnEpidemiology-chn
Epidemiology-chn
 
Problems of healthcare
Problems of healthcareProblems of healthcare
Problems of healthcare
 

Similar to Rare Disease Description (source Eurordis)

Social Media-Rare Disease (Luis Luque, Manuel Armayones)
Social Media-Rare Disease (Luis Luque, Manuel Armayones)Social Media-Rare Disease (Luis Luque, Manuel Armayones)
Social Media-Rare Disease (Luis Luque, Manuel Armayones)
Manuel Armayones
 
Chapter 4Communicable and Noncommunicable Diseases Prevention.docx
Chapter 4Communicable and Noncommunicable Diseases Prevention.docxChapter 4Communicable and Noncommunicable Diseases Prevention.docx
Chapter 4Communicable and Noncommunicable Diseases Prevention.docx
robertad6
 
CURRENT PROBLEMS AND ISSUES IN THE DIAGNOSIS OF ORPHAN DISEASES IN CHILDREN
CURRENT PROBLEMS AND ISSUES IN THE DIAGNOSIS OF ORPHAN DISEASES IN CHILDRENCURRENT PROBLEMS AND ISSUES IN THE DIAGNOSIS OF ORPHAN DISEASES IN CHILDREN
CURRENT PROBLEMS AND ISSUES IN THE DIAGNOSIS OF ORPHAN DISEASES IN CHILDREN
indexPub
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
jangeissler
 
IE: Question A
IE: Question AIE: Question A
IE: Question A
IanSpencer89
 
Recent advance in hiv treatment 1
Recent advance in hiv treatment 1Recent advance in hiv treatment 1
Recent advance in hiv treatment 1
Chetkant Bhusal
 
Guía metabólica and the Rare Diasease Day 2012
Guía metabólica and the Rare Diasease Day 2012Guía metabólica and the Rare Diasease Day 2012
Guía metabólica and the Rare Diasease Day 2012
Hospital Sant Joan de Déu Barcelona
 
EPIDEMIOLOGY
EPIDEMIOLOGYEPIDEMIOLOGY
EPIDEMIOLOGY
JAYDIP NINAMA
 
Tromso Telemedicine Laboratory (TROMSO) Marathon Projects
Tromso Telemedicine Laboratory (TROMSO) Marathon ProjectsTromso Telemedicine Laboratory (TROMSO) Marathon Projects
Tromso Telemedicine Laboratory (TROMSO) Marathon Projects
Manuel Armayones
 
Empowering the European Citizen: the ECDC Web Communication
Empowering the European Citizen: the ECDC Web CommunicationEmpowering the European Citizen: the ECDC Web Communication
Empowering the European Citizen: the ECDC Web Communication
Plan de Calidad para el SNS
 
Communicable disease
Communicable diseaseCommunicable disease
Communicable disease
Waleed Ameen Mohammed
 
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptxHUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
JezzelGraceSalvadorB
 
introductiontoepidemiology-160916102650(0).pdf
introductiontoepidemiology-160916102650(0).pdfintroductiontoepidemiology-160916102650(0).pdf
introductiontoepidemiology-160916102650(0).pdf
Happychifunda
 
Mysticism in Nowadays Romania
Mysticism in Nowadays RomaniaMysticism in Nowadays Romania
Mysticism in Nowadays Romania
Asociatia Secular-Umanista Din Romania
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
Pradhuman Yadav
 
Epidemiology.pptx
Epidemiology.pptxEpidemiology.pptx
Epidemiology.pptx
DrMNASEEMKHAN
 

Similar to Rare Disease Description (source Eurordis) (20)

Social Media-Rare Disease (Luis Luque, Manuel Armayones)
Social Media-Rare Disease (Luis Luque, Manuel Armayones)Social Media-Rare Disease (Luis Luque, Manuel Armayones)
Social Media-Rare Disease (Luis Luque, Manuel Armayones)
 
Chapter 4Communicable and Noncommunicable Diseases Prevention.docx
Chapter 4Communicable and Noncommunicable Diseases Prevention.docxChapter 4Communicable and Noncommunicable Diseases Prevention.docx
Chapter 4Communicable and Noncommunicable Diseases Prevention.docx
 
CURRENT PROBLEMS AND ISSUES IN THE DIAGNOSIS OF ORPHAN DISEASES IN CHILDREN
CURRENT PROBLEMS AND ISSUES IN THE DIAGNOSIS OF ORPHAN DISEASES IN CHILDRENCURRENT PROBLEMS AND ISSUES IN THE DIAGNOSIS OF ORPHAN DISEASES IN CHILDREN
CURRENT PROBLEMS AND ISSUES IN THE DIAGNOSIS OF ORPHAN DISEASES IN CHILDREN
 
90110 pp tx_ch04
90110 pp tx_ch0490110 pp tx_ch04
90110 pp tx_ch04
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
 
IE: Question A
IE: Question AIE: Question A
IE: Question A
 
Recent advance in hiv treatment 1
Recent advance in hiv treatment 1Recent advance in hiv treatment 1
Recent advance in hiv treatment 1
 
Guía metabólica and the Rare Diasease Day 2012
Guía metabólica and the Rare Diasease Day 2012Guía metabólica and the Rare Diasease Day 2012
Guía metabólica and the Rare Diasease Day 2012
 
EPIDEMIOLOGY
EPIDEMIOLOGYEPIDEMIOLOGY
EPIDEMIOLOGY
 
Neglected tropical diseases
Neglected tropical diseasesNeglected tropical diseases
Neglected tropical diseases
 
Tromso Telemedicine Laboratory (TROMSO) Marathon Projects
Tromso Telemedicine Laboratory (TROMSO) Marathon ProjectsTromso Telemedicine Laboratory (TROMSO) Marathon Projects
Tromso Telemedicine Laboratory (TROMSO) Marathon Projects
 
Empowering the European Citizen: the ECDC Web Communication
Empowering the European Citizen: the ECDC Web CommunicationEmpowering the European Citizen: the ECDC Web Communication
Empowering the European Citizen: the ECDC Web Communication
 
Communicable disease
Communicable diseaseCommunicable disease
Communicable disease
 
Session 13 francesc_palau
Session 13 francesc_palauSession 13 francesc_palau
Session 13 francesc_palau
 
Epidemology
EpidemologyEpidemology
Epidemology
 
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptxHUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
HUMAN IMMUNODEFICIENCY VIRUS(FERNANDEZ).pptx
 
introductiontoepidemiology-160916102650(0).pdf
introductiontoepidemiology-160916102650(0).pdfintroductiontoepidemiology-160916102650(0).pdf
introductiontoepidemiology-160916102650(0).pdf
 
Mysticism in Nowadays Romania
Mysticism in Nowadays RomaniaMysticism in Nowadays Romania
Mysticism in Nowadays Romania
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 
Epidemiology.pptx
Epidemiology.pptxEpidemiology.pptx
Epidemiology.pptx
 

More from Manuel Armayones

Behavior Design Lab-eHealth Center-Open University of Catalonia
Behavior Design Lab-eHealth Center-Open University of CataloniaBehavior Design Lab-eHealth Center-Open University of Catalonia
Behavior Design Lab-eHealth Center-Open University of Catalonia
Manuel Armayones
 
Adolescents, Internet i Salut: riscos i oportunitats
Adolescents, Internet i Salut: riscos i oportunitatsAdolescents, Internet i Salut: riscos i oportunitats
Adolescents, Internet i Salut: riscos i oportunitats
Manuel Armayones
 
Redes sociales como herramientas de alfabetización digital en salud:algunas b...
Redes sociales como herramientas de alfabetización digital en salud:algunas b...Redes sociales como herramientas de alfabetización digital en salud:algunas b...
Redes sociales como herramientas de alfabetización digital en salud:algunas b...
Manuel Armayones
 
Alfabetización Digital en Salud: cuestión de "H-Alma"
Alfabetización Digital en Salud: cuestión de "H-Alma"Alfabetización Digital en Salud: cuestión de "H-Alma"
Alfabetización Digital en Salud: cuestión de "H-Alma"
Manuel Armayones
 
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
Manuel Armayones
 
¿Que sabemos sobre la relación entre tecnología y personas?
¿Que sabemos sobre la relación entre tecnología y personas?¿Que sabemos sobre la relación entre tecnología y personas?
¿Que sabemos sobre la relación entre tecnología y personas?
Manuel Armayones
 
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
Manuel Armayones
 
Psicologia 2.0. Retos y Oportunidades
Psicologia 2.0. Retos y OportunidadesPsicologia 2.0. Retos y Oportunidades
Psicologia 2.0. Retos y Oportunidades
Manuel Armayones
 
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
Manuel Armayones
 
Medicine20 stanford armayones
Medicine20 stanford armayonesMedicine20 stanford armayones
Medicine20 stanford armayones
Manuel Armayones
 
Presentation valencia roundtable
Presentation valencia roundtablePresentation valencia roundtable
Presentation valencia roundtable
Manuel Armayones
 
Medicine20 Stanford
Medicine20 StanfordMedicine20 Stanford
Medicine20 Stanford
Manuel Armayones
 
Armayones congreso cronicos_2011
Armayones congreso cronicos_2011Armayones congreso cronicos_2011
Armayones congreso cronicos_2011
Manuel Armayones
 
Algunas reflexiones sobre el futuro de la eSalud
Algunas reflexiones sobre el futuro de la eSaludAlgunas reflexiones sobre el futuro de la eSalud
Algunas reflexiones sobre el futuro de la eSalud
Manuel Armayones
 
Social Media&Rare Diseases
Social Media&Rare DiseasesSocial Media&Rare Diseases
Social Media&Rare Diseases
Manuel Armayones
 
Presentación armayones
Presentación armayonesPresentación armayones
Presentación armayones
Manuel Armayones
 
E salud epacientes
E salud epacientesE salud epacientes
E salud epacientes
Manuel Armayones
 
Online communities as a vehicle to improving interactions between patients an...
Online communities as a vehicle to improving interactions between patients an...Online communities as a vehicle to improving interactions between patients an...
Online communities as a vehicle to improving interactions between patients an...Manuel Armayones
 
Psinet Totana
Psinet TotanaPsinet Totana
Psinet Totana
Manuel Armayones
 
Las Redes Sociales Como Herramientas De IntervencióN Social En Salud
Las Redes Sociales Como Herramientas De IntervencióN Social En SaludLas Redes Sociales Como Herramientas De IntervencióN Social En Salud
Las Redes Sociales Como Herramientas De IntervencióN Social En Salud
Manuel Armayones
 

More from Manuel Armayones (20)

Behavior Design Lab-eHealth Center-Open University of Catalonia
Behavior Design Lab-eHealth Center-Open University of CataloniaBehavior Design Lab-eHealth Center-Open University of Catalonia
Behavior Design Lab-eHealth Center-Open University of Catalonia
 
Adolescents, Internet i Salut: riscos i oportunitats
Adolescents, Internet i Salut: riscos i oportunitatsAdolescents, Internet i Salut: riscos i oportunitats
Adolescents, Internet i Salut: riscos i oportunitats
 
Redes sociales como herramientas de alfabetización digital en salud:algunas b...
Redes sociales como herramientas de alfabetización digital en salud:algunas b...Redes sociales como herramientas de alfabetización digital en salud:algunas b...
Redes sociales como herramientas de alfabetización digital en salud:algunas b...
 
Alfabetización Digital en Salud: cuestión de "H-Alma"
Alfabetización Digital en Salud: cuestión de "H-Alma"Alfabetización Digital en Salud: cuestión de "H-Alma"
Alfabetización Digital en Salud: cuestión de "H-Alma"
 
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
¿Cómo pueden combinarse para ayudarnos a cambiar nuestro comportamiento hacia...
 
¿Que sabemos sobre la relación entre tecnología y personas?
¿Que sabemos sobre la relación entre tecnología y personas?¿Que sabemos sobre la relación entre tecnología y personas?
¿Que sabemos sobre la relación entre tecnología y personas?
 
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
Promoción de la Salud y Cambio de Hábitos: Retos permanentes en una sociedad ...
 
Psicologia 2.0. Retos y Oportunidades
Psicologia 2.0. Retos y OportunidadesPsicologia 2.0. Retos y Oportunidades
Psicologia 2.0. Retos y Oportunidades
 
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
Innovación en investigación en Enfermedades Raras: ePacibard. Inteligencia Co...
 
Medicine20 stanford armayones
Medicine20 stanford armayonesMedicine20 stanford armayones
Medicine20 stanford armayones
 
Presentation valencia roundtable
Presentation valencia roundtablePresentation valencia roundtable
Presentation valencia roundtable
 
Medicine20 Stanford
Medicine20 StanfordMedicine20 Stanford
Medicine20 Stanford
 
Armayones congreso cronicos_2011
Armayones congreso cronicos_2011Armayones congreso cronicos_2011
Armayones congreso cronicos_2011
 
Algunas reflexiones sobre el futuro de la eSalud
Algunas reflexiones sobre el futuro de la eSaludAlgunas reflexiones sobre el futuro de la eSalud
Algunas reflexiones sobre el futuro de la eSalud
 
Social Media&Rare Diseases
Social Media&Rare DiseasesSocial Media&Rare Diseases
Social Media&Rare Diseases
 
Presentación armayones
Presentación armayonesPresentación armayones
Presentación armayones
 
E salud epacientes
E salud epacientesE salud epacientes
E salud epacientes
 
Online communities as a vehicle to improving interactions between patients an...
Online communities as a vehicle to improving interactions between patients an...Online communities as a vehicle to improving interactions between patients an...
Online communities as a vehicle to improving interactions between patients an...
 
Psinet Totana
Psinet TotanaPsinet Totana
Psinet Totana
 
Las Redes Sociales Como Herramientas De IntervencióN Social En Salud
Las Redes Sociales Como Herramientas De IntervencióN Social En SaludLas Redes Sociales Como Herramientas De IntervencióN Social En Salud
Las Redes Sociales Como Herramientas De IntervencióN Social En Salud
 

Recently uploaded

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 

Recently uploaded (20)

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 

Rare Disease Description (source Eurordis)

  • 1. PsiNET Seminar Research Rare Disease and Social Media: an opportunity for the long tai l Luis Fernandez Luque, PhD Student Norut Tromsø (Norway) Manuel Armayones Ruiz, PhD Grupo de Investigación Psinet- Universitat Oberta de Catalunya (Spain) Co-founder Asociación Española de Síndrome de Lowe [email_address] http://in3.uoc.edu/opencms/opencms/webs/grups_de_recerca/psinet/CA/
  • 2. A disease or disorder is defined as rare in Europe when it affects less than 1 in 2000 citizens (Orphan Drug Regulation 141/2000). Rare diseases may affect 30 million European Union citizens . Rare diseases are characterised by a broad diversity of disorders and symptoms that vary not only from disease to disease but also from patient to patient suffering from the same disease. Relatively common symptoms can hide underlying rare diseases, leading to misdiagnosis .
  • 3. Characteristics of rare diseases Rare diseases are often chronic, progressive, degenerative, and often life-threatening Rare diseases are disabling: the quality of life of patients is often compromised by the lack or loss of autonomy High level of pain and suffering for the patient and his/ her family No existing effective cure There are between 6000 and 8000 rare diseases 50% of rare diseases affect children 80% of rare diseases have identified genetic origins. Other rare diseases are the result of infections (bacterial or viral), allergies and environmental causes, or are degenerative and proliferative.
  • 4. Rare disease patients face common problems: Lack of access to correct diagnosis Delay in diagnosis Lack of quality information on the disease Lack of scientific knowledge of the disease Heavy social consequences for patients Lack of appropriate quality healthcare Inequities and difficulties in access to treatment and care Source: Eurordis
  • 5.  
  • 6. Behind the data are real people with real problems http://www.youtube.com/watch?v=M7qirJXWhzc&feature=player_embedded
  • 7.  
  • 8. How can things change? By implementing a comprehensive approach to rare diseases By developing appropriate public health policies By increasing international cooperation in scientific research By gaining and sharing scientific knowledge about all rare diseases, not only the most “frequent” ones By developing new diagnostic and therapeutic procedures By raising public awareness By facilitating the network of patient groups to share their experience and best practices By supporting the most isolated patients and their parents to create new patient communities or patient groups By providing comprehensive quality information to the rare disease community Source: Eurordis

Editor's Notes

  1. Brief description: Internet is a common tool in our daily living that offers new possibilities for communicating and delivering health care treatments. One of these possibilities is to use Internet to create a community where professionals (such as psychologists) and caregivers can work together in order to generate processes to improve the quality of life, by providing caregivers with resources to cope with difficult situations. From this perspective, in this session, two projects aimed to improve quality of life of caregivers will be discussed. Psinet is a research group of the Internet Interdisciplinary Institute of the UOC. We work on Psychology, Health and the Net and now we are working on using the internet to improve the quality of life of different groups of people.